Mike Smith
- Molecular Biology
- Infectious Diseases top 5%
- Immunology top 10%
- Epidemiology
- Genetics
- Co-authors
- Michael E. LaskaGiuseppe CiaramellaÖrn AlmarssonTal ZaksMichael WatsonJames D. ThompsonAlex BulychevJoseph J. Senn
- Topics
- Influenza Virus Research Studies (2 papers)Viral gastroenteritis research and epidemiology (1 paper)Viral Infections and Immunology Research (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Mike Smith
6 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Molecular Biology 670
- Infectious Diseases 412
- Immunology 289
- Epidemiology 179
- Genetics 163
Countries citing papers authored by Mike Smith
This map shows the geographic impact of Mike Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Smith more than expected).
Fields of papers citing papers by Mike Smith
This network shows the impact of papers produced by Mike Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Smith. The network helps show where Mike Smith may publish in the future.
Co-authorship network of co-authors of Mike Smith
This figure shows the co-authorship network connecting the top 25 collaborators of Mike Smith. A scholar is included among the top collaborators of Mike Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Smith. Mike Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trialsbreakdown → | 331 |
| 2 | Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Virusesbreakdown → | 493 |
| 3 | 2 | |
| 4 | 148 | |
| 5 | 79 | |
| 6 | Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999. | 32 |
About Mike Smith
Mike Smith is a scholar working on Transplantation, Infectious Diseases and Cardiology and Cardiovascular Medicine, having authored 6 papers that have together received 1.1k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and Viral Infections and Immunology Research (1 paper). The work is most often cited by research in Infectious Diseases (412 citations), Immunology (289 citations) and Animal Science and Zoology (118 citations). Mike Smith has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Michael E. Laska, Giuseppe Ciaramella, Örn Almarsson, Tal Zaks, Michael Watson, James D. Thompson, Alex Bulychev, Joseph J. Senn, Kimberly J. Hassett and Olga Yuzhakov. Their work appears in journals such as American Journal of Kidney Diseases, Vaccine and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.